Clinical trial
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of…
NCT01503827 · Melanoma and Skin Cancer Trials Limited, Other · Unknown status
Key facts
| NCT number | NCT01503827 |
|---|---|
| Title | Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma |
| Official title | Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial |
| Acronym | WBRTMel |
| Lead sponsor | Melanoma and Skin Cancer Trials Limited, Other |
| Collaborators | Trans Tasman Radiation Oncology Group University of Oxford |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Metastatic Melanoma |
| Intervention type | Radiation |
| Interventions | WBRT |
| Enrollment | 220 |
| Start date | Oct 1, 2007 |
| Primary completion | Sep 1, 2017 |
| Completion | Jun 1, 2022 |
| First posted | Jan 4, 2012 |
| Last update posted | Jan 7, 2021 |
| Countries | Australia, Norway, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: